Online Intervention for Transgender/Nonbinary Young Adults' Experiences With Alcohol and Romantic Relationships
Launched by BOSTON UNIVERSITY · Apr 26, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying an online program called Whole Selves, designed specifically for transgender and nonbinary young adults aged 18 to 30. The program aims to help these individuals think about their experiences with alcohol and romantic relationships. Many existing resources don’t meet the unique needs of transgender and nonbinary people, so this study seeks to create a more tailored approach. Participants will use the Whole Selves program and complete online surveys about their relationships, mental health, and alcohol use, providing feedback to help improve the program.
To qualify for the study, participants must identify as transgender or nonbinary, be between 18 and 30 years old, live in the United States, and be currently in a romantic relationship that started at least six weeks before joining. This study is not yet recruiting participants, but it aims to gather valuable insights to prepare for a larger trial that will test how effective the Whole Selves program really is. Your involvement can help shape resources that better support the needs of transgender and nonbinary young adults.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Self-identify as transgender and/or nonbinary
- • Between 18 and 30 years of age, inclusive
- • Able to read and write in English
- • Residency in the United States
- • Currently in a romantic relationship that began at least six weeks prior to enrollment
- Exclusion Criteria:
- • Prospective participants will be excluded as potentially inauthentic (i.e., not genuinely eligible for the study) based on scoring criteria developed through the investigators' prior online survey research with similar populations.
About Boston University
Boston University, a leading research institution located in Boston, Massachusetts, is dedicated to advancing health sciences through innovative clinical trials and research initiatives. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes and addressing pressing health challenges. Boston University is committed to ethical research practices, patient safety, and the dissemination of findings to foster greater understanding and advancements in medical care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Gabriel R Murchison, PhD MPH
Principal Investigator
Boston University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported